Essex Financial Services, Inc. Gsk PLC Transaction History

Essex Financial Services, Inc.

$2.07 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$42.05 - $47.77 $232,326 - $263,929	-5,525 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$40.23 - $47.74 $40 - $47	1 Added 0.02%	5,525 $241,000
Q4 2021 Feb 11, 2022	BUY	$38.88 - $45.31 $5,287 - $6,162	136 Added 2.52%	5,524 $244,000
Q3 2021 Nov 10, 2021	SELL	$38.79 - $43.16 $14,352 - $15,969	-370 Reduced 6.43%	5,388 $206,000
Q2 2021 Jul 30, 2021	BUY	$36.52 - $41.46 $210,282 - $238,726	5,758 New	5,758 $229,000
Q1 2021 May 11, 2021	SELL	$34.27 - $40.01 $189,376 - $221,095	-5,526 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$34.07 - $39.94 $188,270 - $220,708	5,526 New	5,526 $203,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $226,413 - $340,491	-6,973 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$42.0 - $48.25 $756 - $868	18 Added 0.26%	6,973 $328,000
Q3 2019 Nov 04, 2019	SELL	$40.46 - $43.52 $1,416 - $1,523	-35 Reduced 0.5%	6,955 $297,000
Q2 2019 Jul 30, 2019	BUY	$39.4 - $42.7 $10,598 - $11,486	269 Added 4.0%	6,990 $280,000
Q1 2019 May 02, 2019	BUY	$38.57 - $42.69 $578 - $640	15 Added 0.22%	6,721 $281,000
Q4 2018 Feb 07, 2019	SELL	$37.8 - $42.69 $51,181 - $57,802	-1,354 Reduced 16.8%	6,706 $256,000
Q3 2018 Nov 05, 2018	BUY	$39.75 - $42.69 $4,968 - $5,336	125 Added 1.58%	8,060 $324,000
Q2 2018 Aug 07, 2018	BUY	$39.61 - $42.76 $8,555 - $9,236	216 Added 2.8%	7,935 $320,000
Q1 2018 May 03, 2018	BUY	$36.18 - $40.15 $22,250 - $24,692	615 Added 8.66%	7,719 $302,000
Q4 2017 Feb 07, 2018	SELL	$35.34 - $41.9 $37,107 - $43,995	-1,050 Reduced 12.88%	7,104 $252,000
Q3 2017 Nov 03, 2017	BUY	$39.44 - $41.55 $2,958 - $3,116	75 Added 0.93%	8,154 $331,000
Q2 2017 Aug 07, 2017	BUY	N/A	8,079	8,079 $348,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.

Account